In the Media
News
Press Releases
Active Motif Incorporated Licenses Targeted Transposition Technology to Diagenode S.A.
Proteintech Expands Collaboration With Epigenetics Company Active Motif
Active Motif Partners with Arima Genomics to Launch End-to-End Hi-C Service
Active Motif Partners With Benchsci to Increase Discoverability of Epigenetics-related Products
VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today
VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits
Active Motif and Swift Biosciences partner to develop advancements in epigenetics
Forge Therapeutics and Active Motif to Collaborate on Epigenetic Research and Drug Discovery
ChemPartner and Active Motif Form an Epigenetic Biochemical Technology Alliance
Active Motif Acquires SwitchGear Genomics, Inc. Further Expanding Gene Regulation Product Offerings
Active Motif Acquires Genpathway, Inc. Further Expanding Epigenetics Product Offerings
Active Motif Awarded SBIR Grant to Develop Chromatin IP of Clinical Samples
Active Motif Licenses Methylated-CpG Island Recovery Assay (MIRA) from City of Hope